BridgeBio Oncology Therapeutics
$8.91
0
-$0.12-1.33% Thursday 20:00
Statistics
Day High
9.09
Day Low
8.8
52W High
14.87
52W Low
8.5
Volume
27,957
Avg. Volume
278,129
Mkt Cap
713.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.5233
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-268.09MNet Income
Analyst Ratings
$23.83Average Price Target
The highest estimate is 29.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BBOT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors. Initially formed as a subsidiary of BridgeBio Pharma, it focuses on precision oncology with a pipeline that includes BBO-8520, BBO-10203, and BBO-11818 programs targeting KRAS and PI3K pathways. The company recently went public through a business combination with Helix Acquisition Corp. II, raising approximately $450 million to advance clinical development. The CEO is Dr. Eli Wallace, and the CSO is Dr. Pedro Beltran.
Show more...
CEO
Mr. Eli M. Wallace Ph.D.
Employees
62
Country
KY
ISIN
US1079241022
Listings
0 Comments
Share your thoughts
FAQ
What is BridgeBio Oncology Therapeutics stock price today?▼
The current price of BBOT is $8.91 USD — it has decreased by -1.33% in the past 24 hours. Watch BridgeBio Oncology Therapeutics stock price performance more closely on the chart.
What is BridgeBio Oncology Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BridgeBio Oncology Therapeutics stocks are traded under the ticker BBOT.
What is BridgeBio Oncology Therapeutics market cap?▼
Today BridgeBio Oncology Therapeutics has the market capitalization of 713.09M
When is the next BridgeBio Oncology Therapeutics earnings date?▼
BridgeBio Oncology Therapeutics is going to release the next earnings report on June 03, 2026.
What were BridgeBio Oncology Therapeutics earnings last quarter?▼
BBOT earnings for the last quarter are -0.49 USD per share, whereas the estimation was -0.63 USD resulting in a +22.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BridgeBio Oncology Therapeutics revenue for the last year?▼
BridgeBio Oncology Therapeutics revenue for the last year amounts to 0 USD.
What is BridgeBio Oncology Therapeutics net income for the last year?▼
BBOT net income for the last year is -268.09M USD.
How many employees does BridgeBio Oncology Therapeutics have?▼
As of April 04, 2026, the company has 62 employees.
In which sector is BridgeBio Oncology Therapeutics located?▼
BridgeBio Oncology Therapeutics operates in the Health Care sector.
When did BridgeBio Oncology Therapeutics complete a stock split?▼
BridgeBio Oncology Therapeutics has not had any recent stock splits.
Where is BridgeBio Oncology Therapeutics headquartered?▼
BridgeBio Oncology Therapeutics is headquartered in South San Francisco, KY.